GTCR Mergers and Acquisitions Summary | Mergr GTCRs most common sectors for investment arehealthcare services (16%) and information technology (12%) . Which industries has this organization most actively invested in? About PathGroupFounded in 1965, PathGroup is a premier provider of anatomic, clinical, molecular, and digital pathology services in the United States. Blackstone is an exceptional institution and we expect they will bring resources and perspective that will help us as we continue to serve our limited partners, build our franchise and invest our funds over the long term. Their most recent investment was on Dec 16, 2022, when Senske Lawn & Tree Care raised GTCR has invested in Vector Laboratories on Dec 16, 2022. GTCR Announces Recapitalization of PathGroup Customer Service. Ironshore Insurance provides broker-sourced specialty property and casualty insurance coverages for varying risks. The Firms most common investment types include secondary buyout (24%) and stake purchase (21%). Aydanos a proteger Glassdoor verificando que eres una persona real. GTCR understands the dynamics of business transformation through acquisitions, consolidations and internal growth. Aydanos a proteger Glassdoor y demustranos que eres una persona real. We do this by using extraordinary people and flexible capital to help companies solve problems. GTCR, a leading private equity firm, announced today that it has made a majority investment in PathGroup Holdings LLC ("PathGroup" or the "Company") in partnership with founder and CEO Ben Davis . Claim as much as 50% Off - Best Buy Coupon, Epsteins Private Calendar Reveals Prominent Names, First Republic Bank Is Seized and Bulk Sold to JPMorgan, Fed Set to Raise Rates to 16-Year High and Debate a Pause, Opinion: Randi Weingartens Incredible Covid Memory Loss, Opinion: The Fed Failed but Wants More Power, Opinion: Politico Aims at Gorsuch and Misses, JPMorgan Buys First Republic Bank in Second-Largest U.S. Bank Failure, WSJ Opinion: The Teachers Union Says: 'Don't Blame Us', Why the Fed Raises Interest Rates to Deal With Inflation, WSJ Opinion: Feeling Lucky, Democrats Back Non-Compos Presidential Politics, FBI Raises Reward for Texas Shooting Suspect: We Have Zero Leads. Blackstones GP Stakes business specializes in value-added, long-term partnerships with leading private-market alternative asset management firms. Lamentamos Existing Biocoat management and 1315 Capital, the selling equity sponsor, will retain minority stakes in the Company. Cloud-based e-commerce merchandising, demand generation and order fulfillment platform for retailers and brands. Our top priority at GTCR has always been to serve our limited partners by working to generate strong and consistent investment returns through the disciplined application of our investment strategy. "Biocoat has an excellent track record of developing high-quality biocompatible medical coatings formulations using innovative technologies, and we look forward to investing additional capital to support both organic initiatives and strategic follow-on acquisitions in the medical coatings and broader biomaterials sector," said GTCR Managing Director Luke Marker. To explore GTCRs full profile, request access. How many investments has this organization made over time? This website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Since its inception, GTCR has invested more than$20 billionin over 250 companies. GTCR Announces Strategic Investment from Blackstone GP Stakes Leaders Strategy Investment to Support Growth and Expansion of Biocompatible Medical Device Coatings Provider. GTCR LLC is a Chicago, Illinois-based private equity firm focused on leveraged buyout, leveraged recapitalization, growth capital and rollup transactions. Follow Blackstone on Twitter @Blackstone. Switchboard:+1 (212) 583-5000. Park Place Technologies is an IT company that provided organizations around the globe with post-warranty maintenance and support solutions. Deep Sector Expertise | Portfolio Company Investments - GTCR Kirkland & Ellis served as legal counsel to GTCR and Fried Frank served as legal counsel to Blackstone. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail +1-347-463-5453 We are sorry for the inconvenience. Since its inception, GTCR has invested more than $20 billion in over 250 companies. This platform enables the Company to work with its customers across a wide range of interventional products and medical device segments, including neurovascular, ophthalmology, cardiovascular and other interventional specialties. +1-312-933-4903 In 1998, disagreements between the senior partners led Golder, Thoma, Cressey, Rauner, Inc. split into two private equity firms. Over the past 31 years, Biocoat has developed a diverse base of both blue-chip and emerging medical device customers, a highly experienced team of engineers and scientists, and state-of-the-art manufacturing and R&D facilities. By selecting the relevant option, you certify that it accurately reflects your residency. Sectors of Interest: Aerospace, Business Services, Communications, Consumer Products, Consumer Services, Defense, Education, Electronics, Financial Services, Food, Healthcare Services, Information Technology, Insurance, Leisure, Life Science, Marketing, Media, Medical Products, Safety/Security, Software, Technology Hardware, Transportation, Utilities, Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Going Private, Growth Capital, Recapitalization, Stake Purchase, Geographic Preferences: East US, Midwest US, South US, West US. Illinois CHICAGO, Nov. 2, 2022 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has made a strategic, majority investment in Biocoat Holdings, LLC ("Biocoat" or the "Company"). I have been personally gratified to develop rapport with the GTCR team, and we look forward to our long-term partnership., Ward Young, GP Stakes Managing Director added, Our top priority is to partner with the most successful general partners in private equity. GTCR Announces Investment in Biocoat | Markets Insider Win whats next. Blackstone Announces Significant Investment in Simpli.fi, a Leading Financial Advisors, visit our dedicated website to learn how you can partner with Blackstone. Which industries has this organization had the most exits in? pour nous faire part du problme. real person. GTCR Announces Strategic Investment in Senske Services The firm principally invests in high-growth industries, including financial services & technology, healthcare, information services & technology, and growth business services. GTCR has raised a total of $20.5B across 5 funds, their latest being GTCR Strategic Growth Fund. Since its inception, GTCR has invested more than $20 billion in over 250 companies. kelliek@theharbingergroup.com, Internet Explorer presents a security risk. Learn more at www.biocoat.com. GTCR is a prolific health care investor, with at least 11 current health care portfolio companies and almost 50 past investments. Under Mr. Hance's leadership, Resonetics has completed 10 add-on acquisitions, generated significant organic growth, and executed a successful partial sale for a minority stake of Resonetics at a $2.25 billion enterprise value in November 2021. "Jim Moran and the Biocoat team have built an exciting platform company," said Chip Hance. Nous sommes dsols pour la gne occasionne. The state pension system, which has backed four previous GTCR main buyout funds and two co-investments alongside the firm, is weighing a $50 million commitment to the newest fund, according to the documents. The Company's capabilities include developing and supplying customized coatings formulations, performing coatings application services, and offering coatings equipment solutions. Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie Portions of this site are directed only to persons in certain jurisdictions. PitchBooks data visualizations quickly surface an investors historical investmentsshowing a breakdown of activity by industry, year and region. GTCR Closes $7.5 Billion Investment Fund - PR Newswire Founded in 1991, Biocoat is a leading provider of medical coatings products and services for medical devices in the fast-growing interventional sector. GTCR 300 N. LaSalle Street, Suite 5600, Chicago, Illinois 60654 United States (312) 382-2200 www.gtcr.com info@gtcr.com Profile M&A Activity (207) Portfolio (131) Team (41) Offices (1) M&A Connections (79) M&A Advisors (41) Analytics GTCR is a private equity firm that typically partners with management when pursuing acquisitions. We are especially impressed with GTCRs strategy of investing in transformative growth behind talented executives. Prior to partnering with GTCR, Mr. Hance served as Chief Executive Officer of Creganna Medical, a leading supplier of contract manufacturing services for medical devices, where he significantly grew the business via acquisitions and organic growth before completing a successful sale of the company in 2016 to TE Connectivity. from 8 AM - 9 PM ET. Allspring Global Investments Commences Operations As an Independent Si vous continuez voir ce Dr. Davis said "We are thrilled to announce this recapitalization with GTCR as our new majority shareholder and partner. para informarnos de que tienes problemas. envie um e-mail para Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, GTCR Becomes Signatory to United Nations-Supported Principles for Responsible Investment. Als u dit bericht blijft zien, stuur dan een e-mail to let us know you're having trouble. Private Equity Round - Senske Lawn & Tree Care, Private Equity Round - Visionary Broadband, Private Equity Round - PPC Flexible Packaging, Private Equity Round - Global Claims Services, Private Equity Round - Jet Support Services, Private Equity Round - Antylia Scientific, Diversity Spotlight (US Headquarters Only), Private Equity Round - Vector Laboratories, Wells Fargo Asset Management acquired by GTCR, Total number of diversity investments made by an investor. GTCR Appoints Don McDonough to Lead Business Development for its GTCR is a leading growth-oriented private equity firm with a management-driven approach and business-building investment orientation. Biocoat's custom hydrophilic coatings are lubricious, abrasion resistant, biocompatible and can be applied to a wide range of polymeric and metallic substrates. The partnership will provide GTCRs portfolio companies with access to Blackstones group purchasing program, which leverages the buying power of the $150 billion revenue base across Blackstones entire investment platform. enviando un correo electrnico a "We look forward to supporting the team and expanding the PathGroup platform through organic growth initiatives and additional strategic acquisitions. GTCR is based in Chicago with offices in New York and West Palm Beach. As part of GTCRs Leaders StrategyTM, we seek to identify and partner with talented, accomplished executives with whom we work collaboratively to build and grow our portfolio companies. We look forward to supporting Chip, Jim, and the Biocoat team as the Company continues its aggressive pursuit of follow-on acquisitions in the next chapter of its growth.". Please help us protect Glassdoor by verifying that you're a In the last 3 years, GTCR has acquired 12 companies. GTCR Announces Investment in Biocoat TheChicago-based firm pioneered The Leaders Strategy - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. CHICAGO and NASHVILLE, Tenn., May 13, 2022 /PRNewswire/ --. Kellie Kennedy, Harbinger Group ", "Dr. Davis and the PathGroup team have done an incredible job of building PathGroup intoa unique, scaled lab services business with outstanding clinical services," said Sean Cunningham, Managing Director and Co-Head of Healthcare at GTCR. Transaction Data Systems Announces Acquisition by BlackRock Long Term mega-sized private equity firm investors just like it. This was a Private Equity round raised on Jul 27, 2021. In 2020, GTCR closed on its thirteenth equity fund, GTCR Fund XIII, with $7.5 billion of limited partner capital commitments. scusiamo se questo pu causarti degli inconvenienti. om ons te informeren over dit probleem. Sign In. Equity firm GTCR, formerly headed by Rauner, says it never owned Follow Blackstone on Twitter @Blackstone. Both firms continue to invest primarily through consolidations of specific industries, referred to as roll-ups: GTCR invests through a series of private limited partnerships and its investors include a variety of pension funds (e.g., Washington State Investment Board,[12] Pennsylvania State Employee's Retirement System[13]) endowments and other institutional investors. ein Mensch und keine Maschine sind. Lamentamos pelo inconveniente. The partnership will provide GTCR's portfolio companies with access to Blackstone . Over the past 15 months, we have made three Financial Services & Technology ("FS&T") platform investments: Optimal Blue, RevSpring and Sage Payment Solutions. For more information, please visitwww.gtcr.com. In 2020, GTCR closed on its thirteenth equity fund, GTCR Fund XIII, with $7.5 billion of limited partner capital commitments. Multiple GTCR health care companies have made headlines for lawsuits alleging cancer-causing emissions, poor medical care, billing fraud, and other issues. We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them. For more information, visit pathgroup.com. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. GTCR Announces Strategic Investment from Blackstone GP Stakes You may cancel your subscription at anytime by calling excuses voor het ongemak. Wells Fargo Newsroom - Wells Fargo Enters Agreement with GTCR and Funding. The firm became Golder Thoma & Cressey in 1984, and with the promotion of Bruce Rauner to partner the firm would come to be known as Golder, Thoma, Cressey, Rauner, Inc. (GTCR), although it would still often be referred to as Golder Thoma.[7]. Finally, we have a talented group of investment professionals and staff, and we are dedicated to providing our team with the most opportunity for professional growth and impact, while working in a collaborative and inclusive environment. [5][6] Golder Thoma & Cressey received much of its initial funding from William M. Blair and upon leaving First Chicago, Golder was replaced by John A. Canning, Jr. who would go on to found rival Chicago private equity firm Madison Dearborn. GTCR will also have access to a wide range of other services Blackstone provides internally and to its portfolio companies that leverage Blackstones scale and expertise, including its ESG, sustainability, human capital management, cybersecurity, and product development capabilities. GTCR will consider both equity and mezzanine capital commitments and concentrates its investment activity in consumer products & services, healthcare services, outsourced business services, technology, transaction processing, and pharma/medical products. [3] In the 1970s, Golder built the private equity program at First Chicago Corp.[4] where he is noted primarily for backing Federal Express and for efforts as chairman of the National Venture Capital Association and the National Association of Small Business Investment Companies to change federal laws allowing pensions to invest in private equity. As part of GTCR's Leaders Strategy, Dave King, the former Chairman and CEO of Labcorp, will join the PathGroup Board as Chairman, partnering with Dr. Davis and GTCR to further invest in PathGroup's capabilities across the pathology, molecular, and genetic diagnostics modalities. About GTCR Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Healthcare, Financial Services & Technology, Technology, Media . The Firms most common exit type is trade sale (49%). ", Ben Daverman, Managing Director and Co-Head of Healthcare at GTCR, added: "This represents another example of GTCR executing our unique Leaders StrategyTM investment approach of partnering with outstanding managers to identify opportunities in sectors we have deep experience in. GTCR has deep expertise in the healthcare and lab testing industries and will leverage its prior investment history and resources to help support the continued growth of the Company alongside the PathGroup team. For more information, please visit www.gtcr.com. You will be charged GTCRs largest (disclosed) exit occurred in 2020 when it sold Optimal Blue for $1.8B. GTCR Seeks $9.5 Billion for Newest Main Buyout Fund The buyout manager is looking to raise a fund that is nearly 27% larger than its predecessor as more institutional investors wrestle with.